and distant metastases, respectively), from the original version of the World Health Organization (WHO) staging scheme created in 1980 1 to the more recently published staging schemes. [2] [3] [4] Regional LN metastatic status has been correlated with prognosis in several tumor types and represents a key element for the clinician to devise an appropriate, customized treatment plan for each individual tumorbearing canine patient. 5, 6 Although histopathologic examination was the method originally recommended in the WHO staging system to assess regional LN status, 1 assessment of the regional LNs in veterinary medicine is often performed using fine-needle aspiration cytology (FNAC). As it is a noninvasive, cost-effective, and rapid technique, FNAC is very appealing. In a large retrospective study, tumor staging was the second most common reason for sampling LNs, leading to the submission of 9.3% of LN FNACs. 7 In a prospective study including 37 dogs and 7 cats diagnosed with a variety of tumors (16 carcinomas, 18 sarcomas, 7 mast cell tumors (MCTs), 2 melanomas, and 1 histiocytic sarcoma), the sensitivity and specificity of FNAC (obtained from 41 animals) for assessing regional LNs were 100% and 96%, respectively, with histopathology used as the gold standard. 8 In another prospective study including 28 dogs and 3 cats with oral or maxillofacial neoplasms (10 squamous cell carcinomas, 6
fibrosarcomas, 5 melanomas, and 10 other tumors), the accuracy of FNAC for LN staging was 90.5% when compared with histopathology. 9 In contrast, in a recent large retrospective study, the sensitivity and specificity of FNAC in the detection of LN neoplasia were 66.6% and 91.5%, respectively. 10 However, the latter study was primarily designed to determine the agreement between FNAC and histopathology for diagnosing nodal neoplasia and was not specifically designed to assess the accuracy of FNAC in the setting of solid tumor staging. 10 In human oncology practice, LN extirpation followed by histopathologic examination is often performed to achieve an accurate clinical stage. An advantage of histopathologic examination is to allow the review of multiple serial tissue sections, and to allow the use of a comprehensive immunohistochemistry (IHC) panel and other further assessments (eg, PCR-based assessments), which might be necessary to improve the accuracy of staging. 11 However, depending on the location and the number of LNs removed, LN extirpation can be associated with complications and can have negative impacts on the quality of life of cancer patients. 12 The value of sentinel LN extirpation for the staging of several tumor types is currently under investigation. Many studies report an increase in the suitability of each LN extirpation using this approach, while decreasing the morbidity associated with routine, unguided, and extensive LN dissection. 12, 13 Some studies have investigated the utility of FNAC in the staging of human breast, head, and neck cancers, but the sensitivity of FNAC to detect metastases was generally poor. [14] [15] [16] However, other studies have suggested a role for ultrasound-guided FNACs of sentinel LNs in the staging of other tumor types, in particular when used in a step-wise approach. [17] [18] [19] [20] Only 2 relatively small prospective studies have assessed the accuracy of FNAC for LN staging in dogs, both finding good agreement with histopathology. 8, 9 A more recent, large retrospective location, and lateralization), and LN characteristics (anatomic loca- 
| The diagnostic accuracy of LN FNAC
Lymph nodes with diagnostic FNAC were selected for this analysis.
The sensitivity, specificity, and positive and negative predictive values of FNAC in the detection of nodal metastases were determined for all LNs and subsequently for each tumor group, using histopathologic examination as the gold standard. The influence of factors such as LN enlargement, the time between FNAC and LN extirpation, and LN location, and the inability to achieve agreement between FNAC and histopathology was evaluated. Cases with false-negative and false-positive FNAC reports were reviewed in an attempt to find an explanation for discrepancies with histopathology.
| The significance of nondiagnostic LN FNAC
The proportion of nondiagnostic FNAC was determined overall and for each tumor group. The influence of several factors on the failure to obtain a diagnostic FNAC, such as LN enlargement status, ultrasound guidance, and LN location, was evaluated. The prevalence of histopathologic metastatic diagnoses among the LNs with nondiagnostic FNAC was determined and compared with those that had diagnostic FNACs.
| The significance of multiple nodal metastases
Tumors included in the study were reviewed and separated in 2 groups: tumors that had several LNs aspirated and removed for staging, and tumors that had a single LN assessed. The proportion in each LN location, the prevalence of metastasis, and LN enlargement status were compared between the 2 groups. Among the tumors with multiple LNs assessed using histopathology, the prevalence of metastasis to several LNs was determined. The metastatic patterns of several LNs were reviewed. The performance of FNAC was assessed individually for the 5 previously defined tumor groups (Table 4 ). Grouping FNACs into those which agreed and those which disagreed with the corresponding histopathologies, no significant differences in the time between FNAC and LN extirpation (P = .751), nor in LN enlargement status (P = .587) were found. When compared with the overall agreement between FNAC and histopathologic examination, no significant differences were seen for each LN anatomic location.
| Statistical analyses
Among the 13 false-negative FNAC results, 2, 3, and 8 were from dogs bearing a sarcoma, a malignant melanoma, and a MCT, respectively. In one of the sarcoma cases, the LN was removed 15 days later, and histopathologic examination revealed a completely effaced LN by neoplastic tumor cells. In the second case, the LN was removed a couple of days after the FNAC, and a 400 μm metastatic deposit was noted within the corticomedullary junction. All 3 melanoma-bearing dogs were euthanized within a few months of investigation with distant metastatic diseases. In all 3 cases, pigmented cells and some large nonpigmented cells were observed on FNAC and interpreted as melanophages or macrophages. In 7/8
MCT cases, the corresponding histopathologic classification was HN1 or HN2 according to the previously proposed histopathologic classification scheme. 24 In only one such LN did histopathologic examination reveal a focal effacement of the normal nodal 
Malignant melanomas 37
Oral 32
Cutaneous 5
Mast cell tumors 110
Cutaneous 77
Subcutaneous 20
Mucosal 9
Mucocutaneous 4
Other round cell tumors 19
Oral plasma cell tumor 10
Histiocytic sarcoma 6
Nonepitheliotropic T-cell lymphoma 3 LN, lymph node. and cytokeratin IHC. Both of these dogs were lost to follow-up. In the 2 melanoma cases, uncertainty regarding the ability to diagnose metastatic disease cytologically was mentioned by the clinical pathologist. Melanophages and fewer scattered melanocytes were described on both FNAC and histopathology, but in the latter were interpreted as a drainage reaction rather than a metastasis. Both of these dogs were lost to follow-up. In all 4 MCT cases, uncertainty regarding the ability to diagnose metastatic disease cytologically was expressed by the clinical pathologist. The previously proposed histopathologic criteria could not be applied retrospectively, 24 but no disruption or effacement of normal nodal architecture was reported.
Toluidine Blue staining was performed in one case and was supportive of the nonmetastatic diagnosis made on routine histopathology.
Two of these dogs were lost to follow-up, and the 2 other dogs were free of disease, 1 and 2 years after diagnosis. 
| The significance of nondiagnostic LN FNAC

| Significance of multiple nodal metastases
Of the 189 dogs with tumors included in the study, 88 had at least (n = 6), oral malignant melanomas (n = 4), and sarcomas (n = 1) (Table 5 ).
| DISCUSSION
Lymph node enlargement status was significantly associated with tumor metastasis in our study, which was true for all the tumor groups in this study except for other round cell tumors, and which was possibly due to a type II error. Nevertheless, the prevalence of metastases among nonenlarged LNs was also substantial (15%). This finding is consistent with 1 of the 2 previous studies concerning malignant melanomas, in which the prevalence of metastases among nonenlarged LNs was 15%, 21 similar to our study; however, the rate was 40% in the other study. 27 The overall specificity of FNAC for the detection of tumor metastases found in our study (91%) was similar to that found in a previous study (91.5%); however, the overall sensitivity was superior in our study (81%) compared with this study (66.6%), 11 which could be explained by the features of the previous study in which cytologic and histopathologic examinations were not always performed on the same LN, the time interval between cytologic and histopathologic examinations was up to 80 days, and cases of multicentric lymphoma were included. 10 Nonetheless, our results concur that, although of high value and practicality, LN histopathologic examination cannot always be reliably substituted with FNAC.
The relatively low sensitivity of FNAC for detecting metastatic sarcomas in LNs (67%), also reported in a previous study, 10 could be related, at least in part, to the poorly exfoliative nature of sarcomas, which limits the ability of FNACs to be used for metastatic sarcoma diagnoses. 28 The relatively poor sensitivity of FNAC for detecting metastatic malignant melanomas in LNs (63%) has also been anecdotally reported. 27, 29 In one study assessing the efficacy of systemic adjuvant therapies in dogs with excised oral malignant melanomas, 41 dogs had both cytologic and histopathologic examinations of at least one LN, and the sensitivity and specificity of FNAC were 78.1% and 64.1%, respectively. 29 The specificity found in our study T A B L E 4 Lymph node fine-needle aspiration cytology performance in the detection of tumor metastasis was superior (91%), but these results highlight the difficulty in differentiating melanophages from melanocytes, which is a challenge for both cytologic and histopathologic examinations. The American Joint Committee on Cancer (AJCC) published guidelines for the use of IHC in the evaluation of melanoma-draining sentinel LNs in human oncology practice, to facilitate the distinction between melanocytes and histiocytes. 11 The identification of even single-cell metastases in a sentinel LN is now considered sufficient to categorize patients as having dissemination. 11, 30 The increasing use of sensitive techniques for the detection of melanoma metastasis (IHC, PCR) has added to the challenge of accurately differentiating malignant from benign melanocytes. 31, 32 Although this topic has not been as clearly researched in canine oncology, routine histopathologic examination alone is likely to be a suboptimal gold standard for canine melanoma nodal metastasis assessment. This was highlighted in a recent study, in which the diagnosis of LN melanoma metastasis was changed in 46.9% of dogs after a second opinion was reviewed. 33 This might also explain, in part, why several studies failed to find the prognostic value of using LN FNAC to identify metastatic disease in dogs, 29, 34, 35 while LN metastatic status is of important prognostic value in human melanoma. 36 The robustness of assessment of the diagnostic utility of FNAC for the detection of melanoma nodal metastases would be enhanced by an optimal gold standard, based on the results of a future comparison of histopathology, IHC, PCR, and combinations thereof, and incorporating follow-up visits.
Although one study found perfect agreement between cytologic and histopathologic examinations for the detection of MCT nodal metastasis, 37 the relatively low sensitivity (75%) found in our study is more consistent with that reported in another study (68.7%). 10 Cytologically, it is often challenging to differentiate reactive from well-differentiated neoplastic mast cells within LN aspirates. Clinical pathologists often rely on the presence of overall mast cell numbers, aggregation abilities, and/or morphologic abnormalities to make such a distinction. It is, therefore, often difficult to determine the metastatic status of LNs draining canine MCTs either on cytology or histopathology. Criteria have previously been proposed to standardize the definition of MCT nodal metastasis for both techniques. 24, 25 These criteria were not systematically applied in our study, which makes it difficult to make meaningful comments on the sensitivity and specificity obtained by using the proposed criteria. A prospective study with the systematic application of these criteria for cytologic and histopathologic examinations, together with follow-up visits, would be necessary for a more reliable evaluation of the FNAC accuracy. It should also be understood that in all 4 false-positive
FNACs to assess MCT nodal metastases, the clinical pathologist expressed some uncertainty regarding the metastatic status; and for only 1/8 false-negative FNAC results there was a corresponding histopathologic classification of HN3 (overt metastasis). 24 Furthermore, TB staining invalidated LN metastatic diagnoses initially made on routine histopathology in 1 case, and the systematic use of TB staining might alter the determined sensitivity and specificity of FNAC in the detection of MCT nodal metastasis.
Nondiagnostic FNAC was reported in 25% of our cases. This is comparable to the results of another study (27.2%) although only 9.3% of the LNs sampled were for tumor staging purposes in that study. 7 In another study, only 5.7% of the cytologic samples were deemed nondiagnostic, 10 but again the study did not exclu- The current study had several limitations, most of them being the consequence of its retrospective design. Cytologic and histopathologic examinations were performed by different pathologists all of whom were board-certified, although the sections were not systematically reviewed for this study, which, therefore, contributed to interobserver variation. In particular, previously proposed cytologic and histopathologic criteria for the diagnosis of MCT metastases were not systematically applied. 24, 25 Cytologic findings in some cases do not allow certain diagnoses to be reached, but they can raise a suspicion that needs to be confirmed through other methods; however, for the purpose of the study, metastatic status was dichotomized into "metastatic" and "nonmetastatic." Dogs were assessed by different clinicians, and the recording of LN enlargements was subject to interobserver variation. There was a variable interval between cytologic and histopathologic assessments, which could have affected agreement, although this was intentionally limited. No significant differences were found in the intervals between LN FNAC and histopathologic assessments, in those that showed agreement and in those that did not.
| CONCLUSION S
In our study, FNAC was a reliable tool to detect metastatic carci- 
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